The cost effectiveness of lung transplantation compared with that of heart and liver transplantation in the Netherlands

被引：32

作者：

Ouwens, JP

van Enckevort, PJ

TenVergert, EM

Bonsel, GJ

van der Bij, W

Haagsma, EB

Rutten, FFH

Slooff, MJH

Koëter, GH

机构：

[1] Univ Groningen Hosp, Lung Transplantat Grp, NL-9700 RB Groningen, Netherlands

[2] Univ Groningen Hosp, Off Med Technol Assessment, Groningen, Netherlands

[3] Univ Amsterdam, Acad Med Ctr, Dept Social Med, NL-1105 AZ Amsterdam, Netherlands

[4] Univ Groningen Hosp, Dept Pulmonol, NL-9700 RB Groningen, Netherlands

来源：

TRANSPLANT INTERNATIONAL | 2003年 / 16卷 / 02期

关键词：

cost-benefit analysis; lung transplantation; liver transplantation; heart transplantation;

D O I：

10.1111/j.1432-2277.2003.tb00273.x

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

This study was performed to assess the main reasons for the unfavorable cost effectiveness of lung transplantation compared with that of heart and liver transplantation. Costs, effects, and cost-effectiveness ratios of Dutch lung, heart, and liver transplantation programs were compared. The data are based on three Dutch technology assessments of transplantation, with minor adjustments for time and methods. In result, mainly follow-up costs of lung transplantation are higher than costs of heart and liver transplantation - US $150,300, US $121,500, and US $95,300, respectively - in the first 3 years after transplantation. The survival gain realized by lung transplantation is small (4.4 years) compared with heart (8.8 years) and liver (14.7years) transplantation. Costs per life-year gained were US $77,000, US $38,000, and US $26,000 for lung, heart, and liver transplantation, respectively. The unfavorable cost effectiveness of lung transplantation is largely related to a relatively small survival gain and high follow-up costs.

引用

页码：123 / 127

页数：5

共 19 条

[1] Cost-effectiveness of lung transplantation in the Netherlands - A scenario analysis [J].